-
Signature
-
/s/ John Meloun, as Attorney-in-Fact, for Anthony Geisler
-
Stock symbol
-
XPOF
-
Transactions as of
-
Jun 15, 2023
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
6/20/2023, 09:50 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
XPOF |
Class B Common Stock |
Gift |
$0 |
-4.4K |
-69.03% |
$0.00 |
1.98K |
Jun 15, 2023 |
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F1, F2 |
holding |
XPOF |
Class A Common Stock |
|
|
|
|
|
334K |
Jun 15, 2023 |
Direct |
|
holding |
XPOF |
Class A Common Stock |
|
|
|
|
|
372K |
Jun 15, 2023 |
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F2 |
holding |
XPOF |
Class B Common Stock |
|
|
|
|
|
7.44M |
Jun 15, 2023 |
LAG Fit, Inc. |
F3 |
holding |
XPOF |
Class A Common Stock |
|
|
|
|
|
83.3K |
Jun 15, 2023 |
LAG Fit, Inc. |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
XPOF |
LLC Units in Xponential Holdings LLC |
Gift |
|
-4.4K |
-69.03% |
|
1.98K |
Jun 15, 2023 |
Class A Common Stock |
4.4K |
|
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F2, F4, F5, F6 |
holding |
XPOF |
LLC Units in Xponential Holdings LLC |
|
|
|
|
|
7.44M |
Jun 15, 2023 |
Class A Common Stock |
7.44M |
|
LAG Fit, Inc. |
F3, F4, F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: